IL17A and autoimmune disease: In light of the pathological significance of IL-17A in autoimmune diseases and its therapeutic value as a drug target, an alternative approach to clear IL-17A may complement monoclonal antibody drugs that facing challenges in immunogenicity and the resulted anti-drug antibodies16,17.